Physician profile
Leanora Brown
NPI 1497039234
$3,694.42
in general payments reported to CMS, 2019-2025
33 companies · $1,067 in 2025
The $1,067 reported for 2025 was more than what 86% of Adult Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $186).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $710 · 2022: $511 · 2023: $610 · 2024: $797 · 2025: $1,067.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,349 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,348.61 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $698.65 | 2021-2024 | Axonics |
| Novo Nordisk INC | $336.17 | 2022-2025 | Ozempic, Rivfloza |
| 180 Medical, INC. | $299.45 | 2021-2025 | |
| Abbvie INC. | $290.89 | 2022-2025 | |
| Astellas Pharma US INC | $184.30 | 2021-2025 | Veozah, Myrbetriq |
| Progenics Pharmaceuticals, INC. | $174.96 | 2025 | |
| Antares Pharma, INC. | $147.00 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Sumitomo Pharma America, INC. | $143.24 | 2024-2025 | Gemtesa, Orgovyx |
| Coloplast Corp | $142.56 | 2024-2025 | |
| Tolmar, INC. | $142.04 | 2023-2025 | Jatenzo, Eligard |
| Olympus America INC. | $133.40 | 2023-2025 | Itind System, Soltive, Olympus |
| Teleflex LLC | $97.41 | 2021-2025 | Urolift, Barrigel |
| Allergan, INC. | $84.09 | 2021-2022 | |
| Halozyme INC | $81.65 | 2023 | |
| Acerus Pharmaceuticals Corporation | $78.03 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clarus Therapeutics INC. | $64.42 | 2021 | |
| Endo USA, INC. | $63.78 | 2025 | Aveed, Xiaflex |
| Endo Pharmaceuticals INC. | $62.73 | 2023-2024 | Aveed, Xiaflex, Edex |
| Millicent US INC | $54.37 | 2023-2024 | Intrarosa |
| Hollister Incorporated | $48.80 | 2021 | |
| Innovation Technologies INC | $47.39 | 2025 | Irrisept |
| Urogen Pharma, INC. | $41.18 | 2024 | |
| Procept Biorobotics Corporation | $39.08 | 2023 | Aquabeam Robotic System |
| Myriad Genetic Laboratories, INC. | $35.91 | 2022-2025 | Prolaris |
| Kowa Pharmaceuticals America, INC. | $31.75 | 2022-2023 | Seglentis |
| Ferring Pharmaceuticals INC. | $30.17 | 2024 | Adstiladrin |
| Dendreon Pharmaceuticals LLC | $29.82 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $23.25 | 2023 | Lynparza |
| Boston Scientific Corporation | $20.80 | 2021 | |
| Organon LLC | $19.61 | 2025 | |
| Verity Pharmaceuticals INC. | $17.60 | 2025 | Tlando |
| Novartis Pharmaceuticals Corporation | $15.25 | 2024 | |
| Pfizer INC. | $14.67 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leanora Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.